Evaluation the Safety and Tolerance of GP681 Tablets in Healthy Subjects
Clinical trial NCT04729764 · COMPLETED
Trial details
- NCT number
- NCT04729764
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-27
- Primary completion
- 2020-12-15
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.